Versant Ventures

News, insights, analysis and data

← Back to Versant Ventures profile

Versant Ventures related stories

All articles and analysis

  • Sure Bet?
    Tom Stein- 1 February 2009

    Some venture capitalists are wagering on startups that they believe are recession-proof. BillShrink, eLayaway.com and On Deck Capital are among those that may benefit from the downturn.

  • The Foundry Partners Up
    VCJ Staff- 29 January 2009

    Erik Engelson and Jeffry Grainger have joined medical device incubator The Foundry LLC as managing partners. Engleson previously was president and CEO of Cierra. He also has served in roles with both Versant Ventures and IVP. Grainger previously was VP of corporate affairs and general council with Xtent Inc.

  • PE Week Wire: Thursday, January 29, 2009
    Brad Meikle- 29 January 2009

    Random Ramblings

  • PE Week Wire: Thursday, January 29, 2009
    Brad Meikle- 29 January 2009

    Random Ramblings

  • Week in deals, Jan. 19, 2009
    Brad Meikle- 19 January 2009

    Summary of tech companies and other businesses that raised financing in North America in the past week

  • Exit watch, week of Jan. 19, 2009
    Brad Meikle- 19 January 2009

    News briefs about Medtronic, FlowMedica and other VC-backed companies that were recently acquired

  • Alter-G Raises $8 Million from Versant Ventures
    VCJ Staff- 13 January 2009

    Alter-G, a Menlo Park, Calif.-based developer of rehabilitation and therapy equipment built on anti-gravity technologies originally developed at NASA, has raised $8 million in Series B funding from Versant Ventures. Ross Jaffe of Versant will join the Alter-G board of directors.

  • PE Week Wire: Tuesday, January 13, 2009
    Brad Meikle- 13 January 2009

    Just Linking Around…

  • PE Week Wire: Tuesday, January 13, 2009
    Brad Meikle- 13 January 2009

    Just Linking Around…

  • Medtronic Buying VC-Backed Ablation Frontiers
    VCJ Staff- 12 January 2009

    Medtronic Inc. (NYSE: MDT) has agreed to acquire Ablation Frontiers Inc., a Carlsbad, Calif.-based medical device company focused on developing treatments for irregular heart rhythms. The deal includes an up-front payment of $225 million, plus possible earn-outs based on the achieving of clinical milestones. Ablation Frontiers had raised around $40.3 million in VC funding since 2004, from firms like Novartis Venture Fund, Affinity Ventures, Hexagon Investments, Trellis Health Ventures, Versant Ventures, Aberdare Ventures and Pequot Ventures.